Propranolol Recall Covers One Lot of Blood Pressure Capsules Over Possible Metal Contamination

Propranolol recall graphic with Breckenridge’s official capsule photos and product label beside the affected lot number.

BERKELEY HEIGHTS– A propranolol recall announced Nov. 16 covers one nationwide lot of Breckenridge’s 60-milligram extended-release capsules because of possible metal contamination.

In its recall notice, Breckenridge Pharmaceutical identified Adare Pharma Solutions as the manufacturer. The company reported no known related adverse events.

However, it warned that the product could cut tissue in the mouth, esophagus, stomach, or intestine.

Which Product Is Recalled?

Identifier Recalled product
Medication Propranolol hydrochloride extended-release capsules, USP
Strength 60 mg
Package 100-count bottle
Lot PK25110035
NDC 51991-817-01
Expiration May 2029

Distribution to wholesalers and pharmacies ran from Oct. 26 through Nov. 4, 2026. The notice covers this specific lot.

What Patients Should Do

Breckenridge directs consumers to stop taking capsules from the affected lot immediately and contact their health care provider for advice and replacement instructions. It also asks consumers to return unused recalled medicine to their pharmacy.

However, MedlinePlus warns that suddenly stopping propranolol can cause serious heart problems. Contact your prescriber and pharmacist promptly about the recall and replacement treatment.

Propranolol is a beta blocker used for high blood pressure and several other conditions. According to MedlinePlus, it slows heart rate and relaxes blood vessels. It also has uses involving irregular heartbeats, angina, tremors, and migraine headaches.

The FDA’s recall guidance advises checking the lot number against the recall notice. If you cannot determine whether your prescription matches, ask your pharmacist for help.

Questions and Reporting

Recall questions can also go to Qualanex at 855-736-0807 or recall@qualanex.com, weekdays from 9 a.m. to 5 p.m. Eastern.

Patients can also report medication problems through the FDA’s MedWatch program. MedWatch accepts reports from consumers and health professionals about prescription medicines and other regulated medical products.

NATIONAL NEWS

Download the WEIS Radio app in the Apple App Store and Google Play Store or subscribe to our text alerts here.